Vancomycin
| Effect of ECMO | Minimal impact on drug PK |
|---|---|
| Dose recommendation | ECMO-specific dose adjustment not required |
| Comments, reference | Dosing should be guided mainly by renal function and use of concurrent CRRT. Therapeutic drug monitoring vital to achieve safety and efficacy targets. Ref: Clin Pharmacokinet 2026;65:193. |